Keitaro Doi

479 total citations · 1 hit paper
6 papers, 294 citations indexed

About

Keitaro Doi is a scholar working on Oncology, Surgery and Molecular Biology. According to data from OpenAlex, Keitaro Doi has authored 6 papers receiving a total of 294 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Oncology, 3 papers in Surgery and 2 papers in Molecular Biology. Recurrent topics in Keitaro Doi's work include Pancreatic and Hepatic Oncology Research (3 papers), Cancer Genomics and Diagnostics (2 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (1 paper). Keitaro Doi is often cited by papers focused on Pancreatic and Hepatic Oncology Research (3 papers), Cancer Genomics and Diagnostics (2 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (1 paper). Keitaro Doi collaborates with scholars based in Japan. Keitaro Doi's co-authors include Shigemi Matsumoto, Motoo Nomura, Manabu Muto, Kōichi Inoue, Ryosuke Nagatomo, Tomoki Saito, Kiichiro Baba, Hiroyuki Marusawa, Takehiko Tsumura and Takashi Ura and has published in prestigious journals such as SHILAP Revista de lepidopterología, BMC Cancer and Cancers.

In The Last Decade

Keitaro Doi

5 papers receiving 292 citations

Hit Papers

Association of Short-Chain Fatty Acids in the Gut Microbi... 2020 2026 2022 2024 2020 50 100 150 200 250

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Keitaro Doi Japan 3 226 154 45 44 44 6 294
Kiichiro Baba Japan 5 244 1.1× 176 1.1× 47 1.0× 45 1.0× 53 1.2× 6 351
Gauri Mirji United States 5 198 0.9× 122 0.8× 33 0.7× 37 0.8× 78 1.8× 10 324
Carolina Soto Chervin United States 2 187 0.8× 123 0.8× 27 0.6× 40 0.9× 32 0.7× 2 284
Toshitha Kannan United States 6 218 1.0× 132 0.9× 31 0.7× 38 0.9× 80 1.8× 13 336
Hu Han China 8 297 1.3× 272 1.8× 28 0.6× 47 1.1× 61 1.4× 16 469
Saba Kurtom United States 4 223 1.0× 209 1.4× 22 0.5× 36 0.8× 42 1.0× 9 328
Zoe X. Malchiodi United States 6 238 1.1× 256 1.7× 22 0.5× 36 0.8× 74 1.7× 11 381
Erik Thiele Orberg Germany 6 168 0.7× 110 0.7× 15 0.3× 46 1.0× 59 1.3× 10 251
Megan Folkerts United States 5 171 0.8× 165 1.1× 13 0.3× 42 1.0× 27 0.6× 11 295
Aneta Ševčíková Slovakia 9 179 0.8× 90 0.6× 23 0.5× 24 0.5× 15 0.3× 14 272

Countries citing papers authored by Keitaro Doi

Since Specialization
Citations

This map shows the geographic impact of Keitaro Doi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Keitaro Doi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Keitaro Doi more than expected).

Fields of papers citing papers by Keitaro Doi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Keitaro Doi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Keitaro Doi. The network helps show where Keitaro Doi may publish in the future.

Co-authorship network of co-authors of Keitaro Doi

This figure shows the co-authorship network connecting the top 25 collaborators of Keitaro Doi. A scholar is included among the top collaborators of Keitaro Doi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Keitaro Doi. Keitaro Doi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

6 of 6 papers shown
1.
Kondo, Tomohiro, Masashi Kanai, Junichi Matsubara, et al.. (2023). Association between homologous recombination gene variants and efficacy of oxaliplatin-based chemotherapy in advanced pancreatic cancer: prospective multicenter observational study. Medical Oncology. 40(5). 144–144. 1 indexed citations
2.
Tsumura, Takehiko, Keitaro Doi, & Hiroyuki Marusawa. (2022). Precision Medicine of Hepatobiliary and Pancreatic Cancers: Focusing on Clinical Trial Outcomes. Cancers. 14(15). 3674–3674. 3 indexed citations
3.
Kanai, Masashi, Tadayuki Kou, Keitaro Doi, et al.. (2020). Cancer of unknown primary with EGFR mutation successfully treated with targeted therapy directed by clinical next-generation sequencing: a case report. BMC Cancer. 20(1). 1177–1177. 4 indexed citations
4.
Kondo, Tomohiro, et al.. (2020). Femoral placement of a totally implantable venous access port with spontaneous catheter fracture: case report. SHILAP Revista de lepidopterología. 3(1). 2–2. 2 indexed citations
5.
Nomura, Motoo, Ryosuke Nagatomo, Keitaro Doi, et al.. (2020). Association of Short-Chain Fatty Acids in the Gut Microbiome With Clinical Response to Treatment With Nivolumab or Pembrolizumab in Patients With Solid Cancer Tumors. JAMA Network Open. 3(4). e202895–e202895. 284 indexed citations breakdown →
6.
Koyama, Takashi, Motoo Nomura, Keitaro Doi, Ichiro Tateya, & Manabu Muto. (2019). Re-introducing the same chemotherapy after exposure to anti-PD-1 therapy. International Cancer Conference Journal. 8(2). 86–88.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026